Antibiotic prophylaxis for preventing burn wound infection

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Barajas Nava, Leticia A ^a   López Alcalde, Jesús ^b   Roquéi Figuls, Marta ^a   Solà, Ivan ^a   Bonfill Cosp, Xavier ^c  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b Laín Entralgo Agency   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; BACITRACIN PLUS POLYMYXIN B; CEFAMANDOLE; CEFAZOLIN; CEFORANIDE; CEFOTAXIME; COLISTIN; COTRIMOXAZOLE; ELASE; FLOMOXEF; GENTAMICIN; MAFENIDE ACETATE; NEBACETIN; NEOMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G SODIUM; PENICILLIN V; PIPERACILLIN; PLACEBO; POLYMYXIN B; RIFAMYCIN; SILVER NITRATE; SULFADIAZINE SILVER; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ALLERGIC REACTION; ALOE VERA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTEREMIA; BURN INFECTION; DECONTAMINATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LENGTH OF STAY; MORTALITY; PERIOPERATIVE PERIOD; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPSIS; SKIN TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND HEALING; ARTIFICIAL SKIN; BANDAGE; BURN; CHEMICALLY INDUCED; COMPLICATION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BANDAGES; BURNS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SILVER SULFADIAZINE; SKIN, ARTIFICIAL; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WOUND INFECTION;

EID: 84891709958     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008738.pub2     Document Type: Review

References (138)

1. Alexander JW, MacMillan BG, Law EJ, Krummel R. Prophylactic antibiotics as an adjunct for skin grafting in clean reconstructive surgery following burn injury. Journal of Trauma 1982;22(8):687-90.
2. Alexander JW, MacMillan BG, Law EJ, Kern R. Lack of beneficial effects of restricted prophylactic antibiotics for debridement and/or grafting of seriously burned patients. Bulletin and Clinical Review of Burn Injuries 1984;1:20.
3. Ang ES, Lee ST, Gan CS, See P, Chan YH, Ng LH, et al.The role of alternative therapy in the management of partial thickness burns of the face - experience with the use of moist exposed burn ointment (MEBO)compared with silver sulphadiazine. Annals of the Academy of Medicine 2002;29(1):7-10.
4. Ang ES, Lee ST, Gan CS, See PG, Chan YH, Ng LH, et al.Evaluating the role of alternative therapy in burn wound management: randomized trial comparing moist exposed burn ointment with conventional methods in the management of patients with second-degree burns. Medscape General Medicine 2001;3(12):3-18.
5. Barret JP, Dziewulski P, Ramzy PI, Wolf SE, Desai MH, Herndon DN. Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns. Plastic and Reconstructive Surgery 2000;105(1):62-5.
6. Barret JP, Jeschke MG, Herndon DN. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001;27(5):439-45.
7. Bugmann P, Taylor S, Gyger D, Lironi A, Genin B, Vunda A, et al.A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns 1998;24(7):609-12.
8. Caruso DM, Foster KN, Blome-Eberwein SA, Twomey JA, Herndon DN, Luterman A, et al.Randomized clinical study of Hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. Journal of Burn Care and Research 2006;27(3):298-309.
9. De La Cal MA, Cerdá E, García-Hierro P, van Saene HK, Gómez-Santos D, Negro E, et al.Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Annals of Surgery 2005;241(3):424-30.
10. Demling RH, DeSanti L. Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes). Burns 1999;25(3):256-61.
11. Demling RH, DeSanti L. The potential benefits of a temporary bioactive skin substitute to treat partial-thickness burns of the feet. Wounds: A Compendium of Clinical Research and Practice 2003;15(1):10-5.
12. Desai MH, Rutan RL, Heggers JP, Alvarado MI, McElroy K, Henrdon DN. The role of gentamicin iontophoresis in the treatment of burned ears. Journal of Burn Care and Rehabilitation 1991;12(6):521-4.
13. Durtschi MB, Orgain C, Counts GW, Heimbach DM. A prospective study of prophylactic penicillin in acutely burned hospitalized patients. Journal of Trauma 1982;22(1):11-4.
14. Fisher AJ, Morrison G, van der Riet Rle S. A blind trial of two aerosol sprays in the exposure treatment of burns. South African Medical Journal 1968;42(34):903-5.
15. Gerding RL, Imbembo AL, Fratianne RB. Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns. Journal of Trauma 1988;28(8):1265-9.
16. Gerding RL, Emerman CL, Effron D, Lukens T, Imbembo AL, Fratianne RB. Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine 1990;19(2):121-4.
17. Glat PM, Kubat WD, Hsu JF, Copty T, Burkey BA, Davis W, et al.Randomized clinical study of SilvaSorb gel in comparison to Silvadene silver sulfadiazine cream in the management of partial-thickness burns. Journal of Burn Care and Research 2009;30(2):262-67.
18. Gong Z-H, Yao J, Ji J-F, Yang J, Xiang T. Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [in Chinese]. Journal of Clinical Rehabilitative Tissue Engineering Research 2009;13(42):8373-6.
19. Gotschall CS, Morrison MIS, Eichelberger MR. Prospective randomized study of the efficacy of Mepitel on children with partial-thickness scalds. Journal of Burn Care and Rehabilitation 1998;19(4):279-83.
20. Hauser J, Rossbach O, Langer S, Vogt P, Germann G, Steinau HU, et al.Local therapy of grade IIa burns: Efficacy and tolerability of a new hydrosome wound gel for the local treatment of grade IIa burns as compared with silver sulfadiazine ointment [Lokale Behandlung von Grad-IIa-Verbrennungen. Wirksamkeit und Verträglichkeit eines neuartigen hydrosomalen Wundgels im Vergleich zu Silbersulfadiazin-Creme]. Unfallchirurg 2007;110(11):988-94.
21. Hosseini SN, Karimian A, Mousavinasab SN, Rahmanpour H, Yamini M, Zahmatkesh SH. Xenoderm versus 1% silver sulfadiazine in partial-thickness burns. Asian Journal of Surgery 2009;32(4):234-9.
22. Khorasani G, Hosseinimehr SJ, Azadbakht M, Zamani A, Mahdavi MR. Aloe versus silver sulfadiazine creams for second-degree burns: A randomized controlled study. Surgery Today 2009;39(7):587-91.
23. Kimura A, Mochizuki T, Nishizawa K, Mashiko K, Yamamoto Y, Otsuka T. Trimethoprim-sulfamethoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients. Journal of Trauma 1998;45(2):383-7.
24. Levine BA, Petroff PA, Slade CL, Pruitt BA Jr. Prospective trials of dexamethasone and aerosolized gentamicin in the treatment of inhalation injury in the burned patient. Journal of Trauma 1978;18(3):188-93.
25. Livingston DH, Cryer HG, Miller FB, Malangoni MA, Polk HC Jr, Weiner LJ. A randomized prospective study of topical antimicrobial agents on skin grafts after thermal injury. Plastic and Reconstructive Surgery 1990;86(6):1059-64; discussion 1065.
26. Maya BJ, Covarrubias BA, Romero PA, Licona VL, Claesson BE, Filipsson S, et al.Spray rifamycin and amniotic membranes in second degree burns [Rifamicina spray y membranas amnióticas en quemaduras de segundo grado]. Compendium de Investigaciones Clinicas Latinoamericanas 1986;6(2):73-80.
27. Miller LM, Carboll WB, Hansbrough JF. The effect of antimicrobial prophylaxis for burn wound excision: Ceforanide versus cefazolin. Current Therapeutic Research, Clinical and Experimental 1987;41(6):946-51.
28. Mohammadi AA, Riazi H, Hasheminasab MJ, Sabet B, Mohammadi MK, Abbasi S, et al.Amniotic membrane dressing vs conventional topical antibiotic dressing in hospitalized burn patients. Iranian Red Crescent Medical Journal 2009;11(1):66-70.
29. Moharamzad Y, Panahi Y, Beiraghdar F, Feizi I. Focused Conference Group: P16 - Natural products: Past and future? Clinical efficacy of a topical herbal cream (Aloe vera, Geranium robertianum and Lavandula stoechas) in second-degree burn wounds. Basic and Clinical Pharmacology and Toxicology 2010;107(Suppl. 1):162-69.
30. Muangman P, Chuntrasakul C, Silthram S, Suvanchote S, Benjathanung R, Kittidacha S, et al.Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds. Journal of The Medical Association of Thailand 2006;89(7):953-8.
31. Munster AM, Winchurch RA, Thupari JN, Ernst CB. Reversal of postburn immunosuppression with low-dose polymyxin B. Journal of Trauma 1986;26(11):995-8.
32. Noordenbos J, Dore C, Hansbrough JF. Safety and efficacy of TransCyte for the treatment of partial-thickness burns. Journal of Burn Care and Rehabilitation 1999;20(4):275-81.
33. Rodgers GL, Fisher MC, Lo A, Cresswell A, Long SS. Study of antibiotic prophylaxis during burn wound debridement in children. Journal of Burn Care and Rehabilitation 1997;18(4):342-6.
34. Silver GM, Robertson SW, Halerz MM, Conrad P, Supple KG, Gamelli RL. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study. Journal of Burn Care and Research 2007;28(5):715-9.
35. Soroff HS, Sasvary DH. Collagenase ointment and polymyxin B sulfate/bacitracin spray versus silver sulfadiazine cream in partial-thickness burns: a pilot study. Journal of Burn Care and Rehabilitation 1994;15(1):13-7.
36. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns 1998;24(2):157-61.
37. Tayade MB, Bakhshi GD, Haobijam N. A comparative study of collagen sheet cover versus 1% silver sulphadiazine in partial thickness burns. Bombay Hospital Journal 2006;48(2):http://www.bhj.org/journal/2006_4802_april/html/org_res_263-267.html.
38. Abdel-Razek SM, Abdel-Khalek AH, Allam AM, Shalaby H, Mandoor S, Higazi M. Impact of selective gastrointestinal decontamination on mortality and morbidity in severely burned patients. Annals of Burns and Fire Disasters 2000;XIII(4):1-5.
39. Afilalo M, Dankoff J, Guttman A, Lloyd J. DuoDERM hydroactive dressing versus silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns 1992;18(4):313-6.
40. Ahuja RB, Gupta A, Gur R. A prospective double-blinded comparative analysis of framycetin and silver sulphadiazine as topical agents for burns: A pilot study. Burns 2009;35(5):672-6.
41. Baghel PS, Shukla S, Mathur RK, Randa R. A comparative study to evaluate the effect of honey dressing and silver sulfadiazene dressing on wound healing in burn patients. Indian Journal of Plastic Surgery 2009;42(2):176-81.
42. Branski LK, Herndon DN, Celis MM, Norbury WB, Masters OE, Jeschke MG. Amnion in the treatment of pediatric partial-thickness facial burns. Burns 2008;34(3):393-9.
43. Carneiro PM, Rwanyuma LR, Mkony CA. A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds. Central African Journal of Medicine 2002;48(9-10):105-8.
44. Cason JS, Jackson DM, Lowbury EJL, Ricketts CR. Antiseptic and aseptic prophylaxis for burns: use of silver nitrate and of isolators. British Medical Journal 1966;2(5525):1288-94.
45. De Gracia CG. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns. Burns 2001;27(1):67-74.
46. Deutsch DH, Miller SF, Finley RK. The use of intestinal antibiotics to delay or prevent infections in patients with burns. Journal of Burn Care and Rehabilitation 1990;11(5):436-42.
47. Donati L, Periti P. Antibiotic treatment of burned patients: an Italian multicentre study. Intensive Care Medicine 1994;20(Suppl 4):S30-4.
48. Fang CH, Nathan P, Robb EC, Alexander JW, MacMillan BG. Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second-degree burns. Journal of Burn Care and Rehabilitation 1987;8(3):206-9.
49. Grippaudo FR, Carini L, Baldini R. Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns 2010;36(6):871-5.
50. Huang YS, Li XL, Liao ZJ, Zhang GA, Liu Q, Tang J, et al.Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: Summary report. Zhonghua Shao Shang Za Zhi 2006;22(1):15-8.
51. Huang Y, Li X, Liao Z, Zhang G, Liu Q, Tang J, et al.A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 2007;33(2):161-6.
52. Hunter GR, Chang FC. Outpatient burns: a prospective study. Journal of Trauma 1976;16(3):191-5.
53. Inman RJ, Snelling CF, Roberts FJ, Shaw K, Boyle JC. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection. Burns, Including Thermal Injury 1984;11(1):35-40.
54. Li XL, Huang YS, Peng YZ, Liao ZJ, Zhang GA, Liu Q, et al.Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Zhonghua Shao Shang Za Zhi 2006;22(1):15-8.
55. Lowbury EJ, Jackson DM. Local chemoprophylaxis for burns with gentamicin and other agents. Lancet 1968;1(7544):654-7.
56. Malik KI, Malik MA, Aslam A. Honey compared with silver sulphadiazine in the treatment of superficial partial-thickness burns. International Wound Journal 2010;7(5):413-7.
57. Manuskiatti W, Fitzpatrick RE, Goldman MP, Krejci-Papa N. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. Journal of the American Academy of Dermatology 1999;40(1):77-84.
58. Mashhood AA, Khan TA, Sami AN. Honey compared with 1% silver sulfadiazine cream in the treatment of superficial and partial thickness burns. Journal of Pakistan Association of Dermatologists 2006;16(1):14-9.
59. Miller L, Hansbrough J, Slater H, Goldfarb IW, Kealey P, Saffle J, et al.Sildimac: a new delivery system for silver sulfadiazine in the treatment of full-thickness burn injuries. Journal of Burn Care and Rehabilitation 1990;11(1):35-41.
60. Munster AM, Xiao GX, Guo Y, Wong LA, Winchurch RA. Control of endotoxemia in burn patients by use of polymyxin B. Journal of Burn Care and Rehabilitation 1989;10(4):327-30.
61. Oen IM, van Baar ME, Middelkoop E, Nieuwenhuis MK. Facial Burns Group. Effectiveness of cerium nitrate-silver sulfadiazine in the treatment of facial burns: a multicenter, randomized, controlled trial. Plastic and Reconstructive Surgery 2012;130(2):274e-283e.
62. Ostlie DJ, Juang D, Aguayo P, Pettiford-Cunningham JP, Erkmann EA, Rash DE, et al. Topical silver sulfadiazine vs collagenase ointment for the treatment of partial thickness burns in children: a prospective randomized trial. Journal of Pediatric Surgery 2012;47(6):1204-7.
63. Piel P, Scarnati S, Goldfarb IW, Slater H. Antibiotic prophylaxis in patients undergoing burn wound excision. Journal of Burn Care and Rehabilitation 1985;6(5):422-4.
64. Proctor DS. The treatment of burns: a comparative trial of antibiotic dressings. South African Medical Journal 1971;45(2):231-6.
65. Ramos G, Resta M, Machare Delgado E, Durlach R, Fernandez Canigia L, Benaim F. Systemic perioperative antibiotic prophylaxis may improve skin autograft survival in patients with acute burns. Journal of Burn Care and Research 2008;29(6):917-23.
66. Steer JA, Papini RP, Wilson AP, McGrouther DA, Nakhla LS, Parkhouse N. Randomized placebo-controlled trial of teicoplanin in the antibiotic prophylaxis of infection following manipulation of burn wounds. British Journal of Surgery 1997;84(6):848-53.
67. Subrahmanyam M. Topical application of honey in treatment of burns. British Journal of Surgery 1991;78(4):497-8.
68. Ugburo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GO. An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns 2004;30(1):43-8.
69. Varas RP, O'Keeffe T, Namias N, Pizano LR, Quintana OD, Herrero Tellachea M, et al.A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation 2005;26(4):344-7.
70. Waffle C, Simon RR, Joslin C. Moisture-vapour-permeable film as an outpatient burn dressing. Burns, Including Thermal Injury 1988;14(1):66-70.
71. Maghsoudi H, Salehi F, Khosrowshahi MK, Baghaei M, Nasirzadeh M, Shams R. Comparison between topical honey and mafenide acetate in treatment of burn wounds. Annals of Burns and Fire Disasters 2011;24(3):132-7.
72. Panahi Y, Beiraghdar F, Akbari H, Bekhradi H, Taghizadeh M, Sahebkar A. A herbal cream consisting of Aloe vera, Lavandulastoechas, and Pelargonium roseum as an alternative for silver sulfadiazine in burn management. Asian Biomedicine 2012;6(2):273-8.
73. Alexander JW. When should prophylactic antibiotics be given?. Annals of Surgery 2009;249(4):557-8.
74. Alp E, Coruh A, Gunay GK, Yontar Y, Doganay M. Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. Journal of Burn Care and Research 2012;33(3):379-85.
75. Alsbjörn B, Gilbert P, Hartmann B, Kaźmierski M, Monstrey S, Palao R, et al.Guidelines for the management of partial-thickness burns in a general hospital or community setting recommendations of a European working party. Burns 2007;33(2):155-60.
76. Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 2004;30(7):660-4.
77. Ansermino M, Hemsley C. Intensive care management and control of infection. BMJ 2004;329(7459):220-3.
78. Atoyebi OA, Sowemimo GO, Odugbemi T. Bacterial flora of burn wounds in Lagos, Nigeria: a prospective study. Burns 1992;18(6):448-51.
79. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 2010;340:c241.
80. Bang RL, Sharma PN, Sanyal SC, Al Naijadah I. Septicaemia after burn injury: a comparative study. Burns 2002;28(8):746-51.
81. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine 2008;148(4):295-309.
82. Brychta P, Magnette A. European Practice Guidelines for Burn Care. The Netherlands, 2011.
83. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clinical Microbiology Reviews 2006;19(2):403-34.
84. Curtin F, Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes. Statistics in Medicine 2002;21(5):2145-59.
85. De Macedo JL, Santos JB. Bacterial and fungal colonization of burn wounds. Memórias do Instituto Oswaldo Cruz 2005;100(5):535-9.
86. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
87. DeSanti L. Pathophysiology and current management of burn injury. Advances in Skin and Wound Care 2005;18(6):323-32; quiz 332-4.
88. Edwards R, Harding KG. Bacteria and wound healing. Current Opinion in Infectious Diseases 2004;17(2):91-6.
89. Ergün O, Celik A, Ergun G, Ozok G. Prophylactic antibiotic use in pediatric burn units. European Journal of Pediatric Surgery 2004;14(6):422-6.
90. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns 2004;30(4):357-61.
91. Haq A. Pattern of burn injuries at a Kenyan provincial hospital. Burns 1990;16(3):185-9.
92. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
93. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
94. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
95. Hoogewerf CJ, Van Baar ME, Hop MJ, Nieuwenhuis MK, Oen IMMH, Middelkoop E. Topical treatment for facial burns. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD008058.pub2]
96. Hospenthal DR, Murray CK, Andersen RC, Bell RB, Calhoun JH, Cancio LC, et al.Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society. Journal of Trauma 2011;71(Suppl 2):S210-34.
97. Hyder AA, Peden M, Krug E. Child health must include injury prevention. Lancet 2009;373(9658):102-3.
98. Kumar P. Prophylactic antibiotics in burns. Burns 2006;32(5):655-6.
99. Latarjet J. A simple guide to burn treatment. International Society for Burn Injuries in collaboration with the World Health Organization. Burns 1995;21(3):221-5.
100. Latenser BA, Miller SF, Bessey PQ, Browning SM, Caruso DM, Gomez M, et al.National Burn Repository 2006: a ten-year review. Journal of Burn Care and Research 2007;28(5):635-58.
101. Lee F, Wong P, Hill F, Burgner D, Taylor R. Evidence behind the WHO guidelines: Hospital care for children: What is the role of prophylactic antibiotics in the management of burns?. Journal of Tropical Pediatrics 2009;55(2):73-7.
102. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
103. Louis TA, Lavori PW, Bailar JC, Polansky M. Crossover and self-controlled designs in clinical research. New England Journal of Medicine 1984;310:24-31.
104. Mathers CD, Bernard C, Iburg KM, Inoue M, Ma Fat D, Shibuya K, et al.Global burden of disease in 2002: data sources, methods and results. World Health Organization. Geneva, 2003.
105. Mayahall CG. The epidemiology of burn wound infections: then and now. Clinical Infectious Diseases 2003;37(4):543-50.
106. Merriam-Webster's Collegiate® Dictionary, Eleventh Edition. Available from www.merriam-webster.com/ (accessed 2 May 2012).
107. Miles F, Voss L, Segedin E, Anderson BJ. Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit. Archives of Disease in Childhood 2005;90(12):1274-8.
108. Mills EJ, Chan AW, Wu P, Vail A, Guyatt GH, Altman DG. Design, analysis, and presentation of crossover trials. Trials 2009;10:27.
109. Miniño AM, Anderson RN, Fingerhut LA, Boudreault MA, Warner M. Deaths: injuries, 2002. National Vital Statistics Reports 2006;54(10):1-124.
110. Mock C, Peck M, Peden M, Krug E, Ahuja R, Albertyn H, et al.A WHO plan for burn prevention and care. World Health Organization. Geneva, 2008.
111. Moher D, Schulz KF, Altman D, CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91.
112. Munster AM. Immunologic response of trauma and burns. An overview. American Journal of Medicine 1984;76(3A):142-5.
113. Murphy KD, Lee JO, Herndon DN. Current pharmacotherapy for the treatment of severe burns. Expert Opinion on Pharmacotherapy 2003;4(3):369-84.
114. Murray C, Hospenthal DR. Burn Wound Infections. eMedicine Infectious Diseases (http://emedicine.medscape.com/article/213595-overview) 2008.
115. NSW Severe Burn Injury Service (SBIS). Clinical Practice Guidelines Burn Wound Management. New South Wales, 2008.
116. New Zealand Guidelines Group (NZGG). Management of burns and scalds in primary care. Wellington, NZ., 2007.
117. Onuba O, Udoidiok E. Hospital management of massive burns in the developing countries. Burns, Including Thermal Injury 1987;13(5):386-90.
118. Peden M, McGee K, Sharma G. The injury chart book: a graphical overview of the global burden of injuries. World Health Organization, 2002.
119. Peden M, Oyegbite K, Ozanne-Smith J, Hyder AA, Branche C, Fazlur Rahman AKM, et al.World report on child injury prevention. World Health Organization. Geneva, 2008.
120. Polavarapu N, Ogilvie MP, Panthaki ZJ. Microbiology of burn wound infections. Journal of Craniofacial Surgery 2008;19(4):899-902.
121. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World Journal of Surgery 1998;22(2):135-45.
122. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.1. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration, 22 March 2011.
123. Rosanova MT, Stamboulian D, Lede R. Systematic review: which topical agent is more efficacious in the prevention of infections in burn patients? [Revisión sistemática: ¿Cuál es el agente tópicomás eficaz en la prevención de infeccionesen el paciente quemado?]. Archivos Argentinos de Pediatría 2012;110(4):298-303.
124. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine 2010;152(11):726-32.
125. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene (SEMPSPH). Estudio de prevalencia de las infecciones nosocomiales en España EPINE 1990-2007: 18 años. Madrid, 2012:59 p.
126. Sharma BR. Infection in patients with severe burns: causes and prevention thereof. Infectious Disease Clinics of North America 2007;21(3):745-59, ix.
127. Sheridan RL. Sepsis in pediatric burn patients. Pediatric Critical Care Medicine 2005;6(3 Suppl):S112-9.
128. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random (accessed 8 June 2011).
129. Singer AJ, McClain SA. Persistent wound infection delays epidermal maturation and increases scarring in thermal burns. Wound Repair and Regeneration 2002;10(6):372-7.
130. Soares de Macedo JL, Santos JB. Nosocomial infections in a Brazilian burn unit. Burns 2006;32(4):477-81.
131. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
132. Still J, Law E, Friedman B, Newton T, Wilson J. Clostridium difficile diarrhea on a burn unit. Burns 2002;28(4):398-9.
133. Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD002106.pub3]
134. Weber JM, Sheridan RL, Schulz JT, Tompkins RG, Ryan CM. Effectiveness of bacteria controlled nursing units in preventing cross-colonization with resistant bacteria in severely burned children. Infection Control and Hospital Epidemiology 2002;23(9):549-51.
135. Weber J, McManus A. Infection control in burn patients. Burns 2004;30(8):A16-24.
136. Facts about injuries: burns. World Health Organization and International Society for Burns Injuries. Geneva, 2006.
137. Work Loss Data Institute (WLDI). Burns. Corpus Christi, Texas, 2008.
138. Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nososcomial Infections in a burns intensive care unit. Burns 1995;21(3):181-4.